Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Infect Dis. 2000 Nov;31(5):1202-8. Epub 2000 Nov 6.

Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds.

Author information

1
Department of Pediatrics, Medical University of South Carolina, Charleston, SC 29425, USA. turnerr@musc.edu

Abstract

Two clinical trials were conducted, one involving 273 subjects with experimental rhinovirus colds and the other involving 281 subjects with natural colds. Symptomatic volunteers were randomized to receive oral lozenges containing zinc gluconate (13.3 mg), zinc acetate (5 or 11.5 mg), or placebo. The median duration of illness in zinc gluconate recipients was 2.5 days, contrasted with 3.5 days in the placebo recipients (P=.035), in the experimental colds study. Zinc gluconate had no effect on symptom severity and zinc acetate had no effect on either duration or severity. Neither formulation had an effect on the duration or severity of natural cold symptoms. Evaluation of blinding, taste, and adverse events revealed no significant differences among the 4 treatment arms. Zinc compounds appear to have little utility for common-cold treatment.

PMID:
11073753
DOI:
10.1086/317437
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center